Advertisement

Inpharma Weekly

, Volume 1292, Issue 1, pp 6–6 | Cite as

α-Galactosidase appears to decrease cardiac mass and correct the metabolic defect of Fabry's disease,

Media release
  • 4 Downloads

Keywords

Placebo Clinical Result Placebo Recipient Medium Release Ventricular Hypertrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2001

Personalised recommendations